Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.

BMC pulmonary medicine - 10 Feb 2022

Sin Sooim, Lim Myung-Nam, Kim Jeeyoung, Bak So Hyeon, Kim Woo Jin

Abstract excerpt

BACKGROUND: Higher soluble receptor for advanced glycation end product (sRAGE) levels are considered to be associated with severe emphysema. However, the relationship remains uncertain when the advanced glycation end-product specific receptor (AGER) gene is involved. We aimed to analyse the association between sRAGE levels and emphysema according to the genotypes of rs2070600 in the AGER gene. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Forced Expiratory Volume

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycation End Products, Advanced

Share to Pulmonary Disease, Chronic Obstructive

Share to Pulmonary Emphysema

Share to Receptor for Advanced Glycation End Products

Share to Regression Analysis

Share to Respiratory Function Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 35144588
DOI: 10.1186/s12890-022-01848-9
PMCID: PMC8832795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.PMID 35144588Read ↗

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.Semantic proximity Read ↗

Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of COPD Semantic proximity Read ↗

AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.Semantic proximity Read ↗

Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.Semantic proximity Read ↗

The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.Semantic proximity Read ↗

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene PolymorphismSemantic proximity Read ↗

Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study.Semantic proximity Read ↗

Susceptibility of six polymorphisms in the receptor for advanced glycation end products to type 2 diabetes: a systematic review and meta-analysis.Semantic proximity Read ↗

Age and genetic determinants of variation of circulating levels of the receptor for advanced glycation end products (RAGE) in the general human population.Semantic proximity Read ↗

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Semantic proximity Read ↗

Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.